Home โ€บ Stocks โ€บ ZYDUSLIFE

Zydus Lifesciences Ltd share price

ZYDUSLIFE ยท BSE
โ‚น1,244.00โ–ฒ 58.00 (4.89%)
Open
โ‚น1,187.25
Prev close
โ‚น1,186.00
Day high
โ‚น1,249.00
Day low
โ‚น1,184.55
52-wk high
โ€”
52-wk low
โ€”
See Zydus Lifesciences Ltd live on Traddx Interactive charts, deep fundamentals, peer comparison & your own watchlist โ€” one of 4,800+ NSE & BSE stocks. Free to explore, no card needed.
Open live โ†’
๐Ÿ”” Get a free alert when Zydus Lifesciences Ltd moves Set a price alert, save ZYDUSLIFE to your watchlist, and unlock the full AI deep dive. Free account โ€” 10 seconds with Google, no password.
Create free account โ†’

Zydus Lifesciences Ltd (ZYDUSLIFE) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Pharma theme. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ€” which star investors hold it and who is buying it on today's bulk/block deals tape.

See ZYDUSLIFE live in the app โ†’

Zydus Lifesciences Limited value chain โ€” customers, suppliers & competitors

Zydus Lifesciences is a leading Indian pharmaceutical company that researches, develops, manufactures, and markets a broad range of healthcare therapies, including branded and generic formulations and active pharmaceutical ingredients. It sits in the middle of the healthcare value chain, sourcing chemical raw materials to produce finished medicines sold globally to patients via distributors and healthcare providers.

๐Ÿ›’ Customers โ€” who buys from Zydus Lifesciences Limited

โ›“๏ธ Suppliers โ€” raw materials & inputs

โš”๏ธ Competitors โ€” other sellers

  • Sun Pharmaceutical Industries Limited โ€” Competes across global generic markets and domestic formulations; Sun Pharma is significantly larger.
  • Dr. Reddy's Laboratories Limited โ€” Competes in US generics and domestic branded formulations on product portfolio and R&D capabilities.
  • Cipla Limited โ€” Competes strongly in respiratory and domestic formulations as well as global generic markets.
  • Lupin Limited โ€” Direct peer competing in cardiovascular, anti-infectives, and US generic drug segments.
  • Aurobindo Pharma Limited โ€” Rival generic player competing on cost efficiency and large-scale manufacturing capacity.

๐Ÿ”€ Other suppliers to its customers

๐Ÿค Peers that share its suppliers

  • Lupin Limited โ€” Shares common chemical raw material and packaging vendors.
  • Aurobindo Pharma Limited โ€” Sources similar APIs and chemical intermediates from overlapping chemical suppliers.

This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.